13:39 EDT Tenax Therapeutics (TENX) trading halted, volatility trading pause
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TENX:
- Tenax Therapeutics Approves Officer Exculpation Amendment
- Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
- Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
- Tenax Therapeutics price target lowered to $15 from $16 at Guggenheim
- Tenax Therapeutics reports Q1 EPS (28c), consensus (41c)